Cloning and biological comparison of Restin, novel member of Mage superfamily
Tóm tắt
In the present study, a new member of melanoma associated antigens (Mage), named Restin (219 amino acids), was identified from HL-60 cell induced by all-trans-retinoic acid (ATRA) by PCR-based subtractive hybridization. Bioinformatics analysis found this novel gene shares high homolog with Necdin (a neuronal growth suppressor, 49%). Both of them are basic proteins. Moreover, the Restin, Necdin and Mages are in one protein superfamily. This fact indicates that the Restin and Mages are mutually related but functionally different. Further analysis found that they can be divided into two subgroups, the acid and the basic. Restin, Necdin and Mage-D1 have an alkaline conserve region (PI is from 8.6 to 10.1), which are not or less expressed in tumor tissues but mostly in normal tissues. It has been reported that Necdin can arrest the cell proliferation by interaction with p53 and E2F1. Therefore, all of them are probably related to arrest the cell cycle. However, the Mage A and C are primarily acid proteins (PI is from 4.2 to 4.9), not expressed in normal tissues but in tumors. It is quite probable that these proteins are involved in the cell proliferation. We therefore suggest that these two protein families might be a pair of control elements of cell cycle—“in cycle or out of cycle”.
Tài liệu tham khảo
James, S. Y., Williams, M. A., Newland, A. C. et al., Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D, Gen. Pharmacol., 1999, 32(1): 143–154.
Howard, K., The bioinformatics gold rush, Sci. Am., 2000, 283(1): 58–63.
Eisenberg, D., Marcotte, E. M., Xenarios, I. et al., Protein function in the post-genomic era, Nature, 2000, 15405(6788): 823–826.
Pennisi, E., Human genome. Finally, the book of life and instructions for navigating it, Science, 2000, 288(5475): 2304–2307.
Risch, N. J., Searching for genetic determinants in the new millennium, Nature, 2000, 405(6788): 847–856.
Lin, K. Y., Wright, J., Lim, C., Conformational analysis of long spacers in PROSITE patterns, J. Mol. Biol., 2000, 299(2): 537–548.
Zhao, Z., Huang, X., Li, N. et al., Direct cloning of cell differential expression genes with full-length by a new strategy based on the multiple rounds of “long distance” PCR and magnetic beads mediated subtraction, J. Biotech., 1999, 73: 35–41.
Hayashi, Y., Matsuyama, K., Takagi, K. et al., Arrest of cell growth by necdin, a nuclear protein expressed in postmitotic neurons, Biochem.Biophys.Res.Commun., 1995, 213(1): 317–324.
Taniura, H., Taniguchi, N., Hara, M. et al., Necdin, a postmitotic neuron-specific growth suppressor, interacts with viral transforming proteins and cellular transcription factor E2F1, J. Biol. Chem., 1998, 273(2): 720–728.
Taniura, H., Matsumoto, K., Yoshikawa, K., Physical and functional interactions of neuronal growth suppressor necdin with p53, J. Biol. Chem., 1999, 274(23): 16242–16248.
Heiko, M., Kristian, H., The E2F transcription factors: key regulators of cell proliferation, Biochimica et Biophysica Acta, 2000, 1470: M1-M12.
Adrian, R. B., Azizkhan-Clifford, J., Regulation of E2F: a family of transcription factors involved in proliferation control, Gene, 1999, 237:281–302.
Itoh, K., Hayashi, A., Nakao, M. et al., Human tumor rejection antigens MAGE, J. Biochem. (Tokyo), 1996, 119(3): 385–390.
Boon, T., Cerottini, J. C., Van den Eynde, B. et al., Tumor antigens recognized by T lymphocytes, Annu. Rev. Immunol., 1994; 12: 337–365.
Rosenberg, S. A., Kawakami, Y., Robbins, P. F. et al., Identification of the genes encoding cancer antigens: implications for cancer immunotherapy, Adv.Cancer Res., 1996, 70: 145–177.
Gillespie, A. M., Coleman, R. E., The potential of melanoma antigen expression in cancer therapy, Cancer Treat Rev., 1999, 25(4): 219–227.
Lucas, S., Brasseur, F., Boon, T., A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells, Cancer Res., 1999, 59(16): 4100–4103.